Directed new share issue in CELLINK AB (SE) — SEK 100 million

Carnegie acted as sole bookrunner and lead manager in the directed new share issue of 756,676 new shares at a subscription price of SEK 132.5 per share. CELLINK has created one of the world’s first universal Bioinks, today used by many of the world’s most well-reputed research institutions. June 2018.